Abstract Anthraquinones (9, 10‐dioxoanthracenes) constitute an important class of natural
and synthetic compounds with a wide range of applications. Besides their utilization as …

The discovery of fingolimod (FTY720/Gilenya; Novartis), an orally active immunomodulatory
drug, has opened up new approaches to the treatment of multiple sclerosis, the most …

Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …

Cardiotoxicity, the often-overlooked second leading cause of death in cancer patients, has
been associated with certain anticancer drugs. These drugs can induce cardiac damage …

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous
system (CNS) through demyelination and neurodegeneration. Until recently, major …

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with a
strong autoimmune, neurodegenerative, and neuroinflammatory component. Most of the …

The heart is a target organ for oxidative stress-related injuries. Because of its very high
energetic metabolic demand, the heart has the highest rate of production of reactive oxygen …

During the last two decades, treatment options for patients with multiple sclerosis (MS) have
broadened tremendously. All agents that are currently approved for clinical use have …

In multiple sclerosis (MS) persisting disability can derive from acute relapses or,
alternatively, from slow and steady deterioration, termed chronic progression. Emerging data …

Introduction Multiple sclerosis (MS) is the most common demyelinating disease of the central
nervous system (CNS). Although there are several disease-modifying therapies that can …